{
 "PrintNo":"A9010","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-08-13T10:18:10.285208Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-08-13","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2025-08-13","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL"}],
 "Title":"Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic",
 "Summary":"Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3331 & 3309, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic",
 "SameAsPrintNo":"S6758-2025"
}